What is the current price / NAV of Tata India Pharma & Healthcare Fund?
The current NAV of Tata India Pharma & Healthcare Fund is ₹35.91, as of 4th December 2025.What are the returns of Tata India Pharma & Healthcare Fund?
The Tata India Pharma & Healthcare Fund was launched on 28th December 2015. This mutual fund's past returns are as follows:- 1 Year Returns: 1.29%
- 3 Year Returns: 23.23%
- 5 Year Returns: 17.93%
What are the top 5 sectoral holdings of Tata India Pharma & Healthcare Fund?
The top sectors Tata India Pharma & Healthcare Fund has invested in are as follows:- Pharmaceuticals | 61.23%
- Labs & Life Sciences Services | 33.30%
- Others | 2.28%
- Fertilizers & Agro Chemicals | 2.17%
- Miscellaneous | 0.98%
What are the top 5 holdings of Tata India Pharma & Healthcare Fund?
The top 5 holdings for Tata India Pharma & Healthcare Fund are as follows:- Sun Pharmaceutical Industries Ltd | 9.59%
- Apollo Hospitals Enterprise Ltd | 5.13%
- Healthcare Global Enterprises Ltd | 4.96%
- Lupin Ltd | 4.90%
- Max Healthcare Institute Ltd | 4.71%
What is the asset allocation of Tata India Pharma & Healthcare Fund?
The asset allocation for Tata India Pharma & Healthcare Fund is as follows:- Equity | 98.50%
- Cash & Equivalents | 1.50%
What is the AUM of Tata India Pharma & Healthcare Fund?
The AUM (i.e. assets under management) of Tata India Pharma & Healthcare Fund is ₹1324.90 Cr as of 4th December 2025.What is the expense ratio of Tata India Pharma & Healthcare Fund?
The expense ratio of Tata India Pharma & Healthcare Fund Plan is 0.62 as of 4th December 2025.What is the alpha ratio of Tata India Pharma & Healthcare Fund?
The alpha ratio for the Tata India Pharma & Healthcare Fund is 7.09
Alpha is the excess return of a fund compared to its expected return, based on its beta and the risk-free rate. Positive alpha indicates that the fund has outperformed its expected return, while negative alpha suggests underperformance.
What is the volatility or standard deviation of Tata India Pharma & Healthcare Fund?
The volatility or standard deviation for the Tata India Pharma & Healthcare Fund is 14.34
Standard deviation measures the volatility or risk associated with the returns of a mutual fund. A higher standard deviation indicates higher volatility, suggesting that the returns of the mutual fund are more spread out from the average. On the other hand, a lower standard deviation implies lower volatility and a more stable performance.
What is the sharpe ratio of Tata India Pharma & Healthcare Fund?
The Sharpe ratio for the Tata India Pharma & Healthcare Fund is -0.12
The Sharpe ratio is a measure of risk-adjusted return that evaluates the performance of a mutual fund, by adjusting for its risk. Higher Sharpe ratio indicates a better risk-adjusted performance. A positive Sharpe ratio indicates that the MF has provided a return in excess of the risk-free rate for the amount of risk taken. Conversely, a negative Sharpe ratio suggests that the MF did not adequately compensate for the risk.
What is the Sortino ratio of Tata India Pharma & Healthcare Fund?
The Sortino Ratio for the Tata India Pharma & Healthcare Fund is -0.01
The Sortino ratio of a mutual fund is a measure of its risk-adjusted return, considering only downside volatility. It helps investors evaluate how well a fund is performing relative to its downside risk. A higher Sortino ratio (value >1) means the fund generates better returns for the downside risk taken.
What is the Price to Earnings (PE) ratio of Tata India Pharma & Healthcare Fund?
The PE ratio of Tata India Pharma & Healthcare Fund is 44.65, while category PE ratio is 42.46.

Gains are treated as short-term capital gains and taxed at 20%
Gains are treated as long-term capital gains and taxed at 12.5%